Stephen Redenti
Overview
Explore the profile of Stephen Redenti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
812
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Einbond L, Zhou J, Huang K, Castellanos M, Mbazor E, Balick M, et al.
Viruses
. 2025 Jan;
17(1).
PMID: 39861845
This study explores the effects of plant compounds on human papillomavirus (HPV)-induced W12 cervical precancer cells and bioelectric signaling. The aim is to identify effective phytochemicals, both individually and in...
2.
Seigel G, Onwumere O, Sauane M, Lopez S, Shang E, Habiba H, et al.
Pathol Res Pract
. 2024 Jun;
260:155392.
PMID: 38880039
In this study, we tested the hypothesis that ALYREF/THOC4, a poor prognostic factor in different cancer types, has potential as a drug target and prognostic biomarker for retinoblastoma (RB). Immunostaining...
3.
Gharbaran R, Sayibou Z, Atamturktur S, Ofosu-Mensah J, Soto J, Boodhan N, et al.
J Biochem Mol Toxicol
. 2023 Sep;
38(1):e23527.
PMID: 37681557
Diminazene aceturate (DIZE) is an FDA-listed small molecule known for the treatment of African sleeping sickness. In vivo studies showed that DIZE may be beneficial for a range of human...
4.
Shi C, Huang K, Soto J, Sankaran R, Kalia V, Onwumere O, et al.
Biomed Pharmacother
. 2023 Mar;
161:114554.
PMID: 36940616
Ocular retinoblastoma malignancies, which develop into metastatic phenotypes, result in poor prognosis and survival for infant and child patients. To improve the prognosis of metastatic retinoblastoma, it is important to...
5.
Mighty J, Rubio-Navarro A, Shi C, Zhou J, Flores-Bellver M, Heissel S, et al.
Front Endocrinol (Lausanne)
. 2023 Jan;
13:1077644.
PMID: 36686464
Introduction: Diabetic Retinopathy (DR) is a potentially blinding retinal disorder that develops through the pathogenesis of diabetes. The lack of disease predictors implies a poor prognosis with frequent irreversible retinal...
6.
Flores-Bellver M, Mighty J, Aparicio-Domingo S, Li K, Shi C, Zhou J, et al.
J Extracell Vesicles
. 2021 Nov;
10(13):e12165.
PMID: 34750957
Age-related macular degeneration (AMD) is a leading cause of blindness worldwide. Drusen are key contributors to the etiology of AMD and the ability to modulate drusen biogenesis could lead to...
7.
Zhou J, Flores-Bellver M, Pan J, Benito-Martin A, Shi C, Onwumere O, et al.
Sci Rep
. 2021 Oct;
11(1):21128.
PMID: 34702879
The mechanisms underlying retinal development have not been completely elucidated. Extracellular vesicles (EVs) are novel essential mediators of cell-to-cell communication with emerging roles in developmental processes. Nevertheless, the identification of...
8.
Gharbaran R, Shi C, Onwumere O, Redenti S
Anticancer Res
. 2021 Oct;
41(10):4725-4732.
PMID: 34593421
Background/aim: We investigated the cytotoxic effects of plumbagin on metastatic retinoblastoma, using the highly metastatic cell line Y79. Materials And Methods: Effect of plumbagin on cell growth was assessed with...
9.
Gharbaran R, Onwumere O, Codrington N, Somenarain L, Redenti S
Acta Histochem
. 2020 Dec;
123(1):151657.
PMID: 33259941
Prolactin receptor (PRLR), a type-1 cytokine receptor, is overexpressed in a number of cancer types. It has attracted much attention for putative pro-oncogenic roles, which however, remains controversial in some...
10.
Einbond L, Zhou J, Wu H, Mbazor E, Song G, Balick M, et al.
Br J Cancer
. 2020 Dec;
124(5):901-913.
PMID: 33257842
Background: The phytochemical mixture TriCurin (curcumin, epigallocatechin gallate (EGCG) and resveratrol) eliminates human papillomavirus (HPV) (+) cancer cells in vitro and in vivo. In this study, we further evaluate TriCurin....